logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Influenza A M2 Protein Inhibitor class drugs

    FiltersReset Filters
    3 results

    • amantadine hydrochloride

      (amantadine hydrochloride)
      Upsher-Smith Laboratories, LLC
      Usage: Amantadine hydrochloride tablets are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for treating parkinsonism and drug-induced extrapyramidal reactions. It supports immune response development post-vaccination and is specifically effective in uncomplicated respiratory illnesses due to influenza A.

    • amantadine hydrochloride

      (Amantadine Hydrochloride)
      Chartwell RX, LLC
      Usage: Amantadine hydrochloride oral solution is indicated for the prophylaxis and treatment of influenza A virus infections, as well as for treating Parkinson's disease and drug-induced extrapyramidal reactions. It is not a substitute for vaccination and may have limitations in efficacy due to resistance mutations in influenza viruses.

    • gocovri

      (AMANTADINE)
      Adamas Pharma, LLC
      Usage: GOCOVRI® is indicated for treating dyskinesia in Parkinson’s disease patients on levodopa therapy, with or without additional dopaminergic medications, and as an adjunctive treatment to levodopa/carbidopa for patients experiencing “off” episodes.